Facebook Activity Earns Zarbee's a Slap on the Wrist from FDA

The FDA continued their focus on social media by coming down on Zarbee's for activity on the company’s Facebook page.  Zarbee's, a company focusing on natural cough remedies for young children, received a letter from the FDA outlining transgressions within (relatively) recent social media activity.  The letter specifically focused on Facebook activity including likes on certain comments as well as two tweets from earlier this year.  Most of the highlighted activity took place in January and February of this year although two posts from October 2013 are mentioned as well.  Some of the specific posts cited include:“Liking” the Facebook comment, “…I received your…Zarbee’s Naturals Children’s Sleep Product. I have a daughter…born with cerebral palsy and she suffers from Complex Regional Pain Syndrome… [s]he took the samples you sent and slept through the night…best sleep she has had in years…”“Liking” the Facebook comment, “…It is the best thing for my granddaughters bronchitis.”Tweeting: Try @Zarbees #naturalremedies for Cold and Cough Season…Tweeting: RT @MomCentral Have you tried #ZarbeesCough for cold and cough relief?According to the letter, the company overstepped their boundaries by representing their products as drugs when they endorsed these comments.  The FDA explained, “Your products are not generally recognized as safe and effective for the above referenced uses and, therefore, these products are “new ...
Source: ePharma Summit - Category: Medical Marketing and PR Tags: #epharma ePharma Summit epharma West FDA Social Media FDA Social media guidance FDA social media guidelines Zarbees Zarbees Facebook Zarbees FDA Source Type: blogs